115 related articles for article (PubMed ID: 19010993)
1. High-sensitive C-reactive protein is associated with reduced lung function in young adults.
Rasmussen F; Mikkelsen D; Hancox RJ; Lambrechtsen J; Nybo M; Hansen HS; Siersted HC
Eur Respir J; 2009 Feb; 33(2):382-8. PubMed ID: 19010993
[TBL] [Abstract][Full Text] [Related]
2. No relationship between lung function and high-sensitive C-reactive protein in adolescence.
Nybo M; Hansen HS; Siersted HC; Rasmussen F
Clin Respir J; 2010 Oct; 4(4):230-6. PubMed ID: 20887346
[TBL] [Abstract][Full Text] [Related]
3. Systemic inflammation and lung function in young adults.
Hancox RJ; Poulton R; Greene JM; Filsell S; McLachlan CR; Rasmussen F; Taylor DR; Williams MJ; Williamson A; Sears MR
Thorax; 2007 Dec; 62(12):1064-8. PubMed ID: 17604302
[TBL] [Abstract][Full Text] [Related]
4. Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study.
Kony S; Zureik M; Driss F; Neukirch C; Leynaert B; Neukirch F
Thorax; 2004 Oct; 59(10):892-6. PubMed ID: 15454657
[TBL] [Abstract][Full Text] [Related]
5. CRP is associated with lung function decline in men but not women: a prospective study.
Ólafsdóttir IS; Gíslason T; Gudnason V; Benediktsdóttir B; Ólafsson Í; Aspelund T; Thjódleifsson B; Janson C
Respir Med; 2013 Jan; 107(1):91-7. PubMed ID: 23083841
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein levels in the serum of asthmatic patients.
Fujita M; Ueki S; Ito W; Chiba T; Takeda M; Saito N; Kayaba H; Chihara J
Ann Allergy Asthma Immunol; 2007 Jul; 99(1):48-53. PubMed ID: 17650829
[TBL] [Abstract][Full Text] [Related]
7. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects.
Aronson D; Roterman I; Yigla M; Kerner A; Avizohar O; Sella R; Bartha P; Levy Y; Markiewicz W
Am J Respir Crit Care Med; 2006 Sep; 174(6):626-32. PubMed ID: 16778162
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2.
Bridevaux PO; Gerbase MW; Schindler C; Dietrich DF; Curjuric I; Dratva J; Ackermann-Liebrich U; Probst-Hensch NM; Gaspoz JM; Rochat T
Eur Respir J; 2009 Aug; 34(2):332-9. PubMed ID: 19251780
[TBL] [Abstract][Full Text] [Related]
9. Airflow limitation, lung volumes and systemic inflammation in a general population.
Gläser S; Ittermann T; Koch B; Völzke H; Wallaschofski H; Nauck M; Warnke C; Vogelmeier C; Schulz H; Felix SB; Ewert R; Schäper C
Eur Respir J; 2012 Jan; 39(1):29-37. PubMed ID: 21719491
[TBL] [Abstract][Full Text] [Related]
10. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study.
Shaaban R; Kony S; Driss F; Leynaert B; Soussan D; Pin I; Neukirch F; Zureik M
Respir Med; 2006 Dec; 100(12):2112-20. PubMed ID: 16650972
[TBL] [Abstract][Full Text] [Related]
11. Baseline forced expiratory volume in the first second as an independent predictor of development of the metabolic syndrome.
Hsiao FC; Wu CZ; Su SC; Sun MT; Hsieh CH; Hung YJ; He CT; Pei D
Metabolism; 2010 Jun; 59(6):848-53. PubMed ID: 20006363
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity C-reactive protein in asthma.
Takemura M; Matsumoto H; Niimi A; Ueda T; Matsuoka H; Yamaguchi M; Jinnai M; Muro S; Hirai T; Ito Y; Nakamura T; Mio T; Chin K; Mishima M
Eur Respir J; 2006 May; 27(5):908-12. PubMed ID: 16707391
[TBL] [Abstract][Full Text] [Related]
13. Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity.
Vandevoorde J; Verbanck S; Schuermans D; Broekaert L; Devroey D; Kartounian J; Vincken W
Eur Respir J; 2008 Feb; 31(2):391-5. PubMed ID: 17928313
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein in bronchoalveolar lavage fluid is associated with markers of airway inflammation after lung transplantation.
Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Willems-Widyastuti A; Dupont LJ; Van Raemdonck DE; Verleden GM
Transplant Proc; 2009 Oct; 41(8):3409-13. PubMed ID: 19857759
[TBL] [Abstract][Full Text] [Related]
15. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y
Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197
[TBL] [Abstract][Full Text] [Related]
16. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma.
van Veen IH; Ten Brinke A; Sterk PJ; Rabe KF; Bel EH
Allergy; 2008 May; 63(5):570-4. PubMed ID: 18394131
[TBL] [Abstract][Full Text] [Related]
17. Systemic inflammation, genetic susceptibility and lung function.
Sunyer J; Pistelli R; Plana E; Andreani M; Baldari F; Kolz M; Koenig W; Pekkanen J; Peters A; Forastiere F
Eur Respir J; 2008 Jul; 32(1):92-7. PubMed ID: 18385179
[TBL] [Abstract][Full Text] [Related]
18. Effects of ozone on normal and potentially sensitive human subjects. Part II: Airway inflammation and responsiveness to ozone in nonsmokers and smokers.
Frampton MW; Morrow PE; Torres A; Voter KZ; Whitin JC; Cox C; Speers DM; Tsai Y; Utell MJ
Res Rep Health Eff Inst; 1997 Jun; (78):39-72; discussion 81-99. PubMed ID: 9387196
[TBL] [Abstract][Full Text] [Related]
19. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases].
Wu SJ; Chen P; Jiang XN; Liu ZJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395
[TBL] [Abstract][Full Text] [Related]
20. High-sensitivity C reactive protein as a biomarker for grading of childhood asthma in relation to clinical classification, induced sputum cellularity, and spirometry.
Deraz TE; Kamel TB; El-Kerdany TA; El-Ghazoly HM
Pediatr Pulmonol; 2012 Mar; 47(3):220-5. PubMed ID: 21960260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
